This inventor holds 2 USPTO granted patents. Top assignee: Hoechst Pharmaceuticals & Chemicals K.k.. Active years: 1998-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2000
Title: Kenji Ogata: Innovator in Therapeutic Solutions
Introduction
Kenji Ogata is a prominent inventor based in Otawara, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic agents for autoimmune diseases. With a total of 2 patents, Ogata's work is recognized for its potential impact on health and medicine.
Latest Patents
Ogata's latest patents include innovative solutions such as peptides and therapeutic agents aimed at treating autoimmune diseases. Additionally, he has developed preventive and remedial measures for type 1 allergic diseases. These advancements showcase his commitment to addressing critical health challenges.
Career Highlights
Kenji Ogata is associated with Hoechst Pharmaceuticals & Chemicals K.K., where he has been instrumental in research and development. His work at this company has allowed him to focus on creating effective therapeutic solutions that can improve patient outcomes.
Collaborations
Ogata has collaborated with notable colleagues, including Yukio Amano and Yuko Mizushima. These partnerships have fostered a collaborative environment that enhances innovation and research in the pharmaceutical sector.
Conclusion
Kenji Ogata's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an innovator. His work continues to pave the way for advancements in therapeutic solutions for autoimmune and allergic diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile